Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

ProPhase Labs (PRPH) Cost of Revenue: 2009-2024

Historic Cost of Revenue for ProPhase Labs (PRPH) over the last 16 years, with Dec 2024 value amounting to $6.9 million.

  • ProPhase Labs' Cost of Revenue fell 16.24% to $1.0 million in Q3 2025 from the same period last year, while for Sep 2025 it was $4.1 million, marking a year-over-year increase of 30.64%. This contributed to the annual value of $6.9 million for FY2024, which is 64.38% down from last year.
  • ProPhase Labs' Cost of Revenue amounted to $6.9 million in FY2024, which was down 64.38% from $19.4 million recorded in FY2023.
  • In the past 5 years, ProPhase Labs' Cost of Revenue registered a high of $52.0 million during FY2022, and its lowest value of $6.9 million during FY2024.
  • For the 3-year period, ProPhase Labs' Cost of Revenue averaged around $26.1 million, with its median value being $19.4 million (2023).
  • As far as peak fluctuations go, ProPhase Labs' Cost of Revenue surged by 273.98% in 2021, and later crashed by 64.38% in 2024.
  • Yearly analysis of 5 years shows ProPhase Labs' Cost of Revenue stood at $9.9 million in 2020, then surged by 273.98% to $37.1 million in 2021, then skyrocketed by 40.32% to $52.0 million in 2022, then plummeted by 62.63% to $19.4 million in 2023, then crashed by 64.38% to $6.9 million in 2024.